MTOR and urinary bladder carcinoma: The mechanisms underpinning the oncogenic mode of action of MIR4435-2HG in bladder cancer cells may involve the phosphorylation of mTOR signaling molecules, in which MIR4435-2HG may act as a scaffold for the recruitment of activators.